Q: Its been flat for 10 years now. Before Paladin Labs took off how long was the stock doing nothing before it was taken out? Are there signs that should monitored that will show things are about to inflect? They keep buying back lots of shares and presumably executing on their strategy.
Q: Peter and His Wonder Team
Of course I am a long time holder of this company and a down a ton. Do you think this company has any ability to advance? I am down so much it seems better to wait if it has any chance to progress. In other words I have a lot more to gain than lose by waiting...if you know what I mean. On the other hand I know we have to accept our losses. Thanks for your opinion!
Can you please confirm the FY24 and FY25 consensus EPS as seen on your Key Ratios company page for WELL. It seems the EPS is forecast to drop approx 40%.... .17 cents vs .12 cents respectively which does not seem very enticing. Although many of the other key ratios do look attractive so I wonder what is keeping this stock from performing better?
I have owned WELL for awhile now (marginally ahead) but my patience is growing thin and was thinking of splitting some of the proceeds (if I sell) towards Vitalhub and/or Kneat (which are both now close to their 52 week highs vs WELL) as part of my small cap health exposure. I took part in a DKAM update yesterday and they have VHI and KSI as part of their top 10 stocks for 2025 and I have followed some of their recommendations for years and done very well.
Just curious what your favourite is of these 3 health stocks. In the past you have suggested all 3 as favourable at various times but I know acquisitions etc can move some stocks ahead of others and all have made recent headlines.
Q: I've been considering buying TVK for some time. One of the things holding me back is the potential of a Trump victory and the subsequent imposition of 20% across the board import tarrifs. Given the resource industries that TVK supports, what impact on share price would you predict such tarrifs would have? Would you suggest prospective buyers of TVK wait until after the election to wade in?
Q: In June this year you named this company as one of your favorite cyclicals. I didn't buy it but it has dropped significantly since then. I am considering buying it now as it looks like EPS has exceeded expectations for at least the last 4 Q's. Would you still consider it a buy or have fundamentals changed? Thank you. John
Q: Just finished reading both questions and your report on CPH ..... I don't see any resemblance between your report and the current company .... Could you give me the " Cole's Notes " review of the state of the current company ? What's positive in the pipeline ? What's negative ? I see the failure of the nail fungus drug initially dropped the stock $5 but it has recovered since. Does that mean the drug is not dead ? Thanks for your terrific service ..... { any plans to update that report ? }
Q: Hello 5i research, could you give me a current standing on Archer Aviation compare to similar companies? Is there another prospect in the field of short distance aviation that is worth considering to hold? I would like to buy ACHR and hold fit or the next 5 years.
Q: Any update and your analysis if this company will ever be going to be reward its shareholders with good working. So far it only dilutes it shares every 3 or 4 years by merging or acquiring other small companies.
Thanks
Piyush
Q: Your analysis of the company as a transportation sector. Its quality of earning as operating in Transportation sector. How you see it being a small cap stock in transportation sector where big players are TFI:T, CNR:T or CP:T? Is it good small cap to keep for future growth.
Thanks
Piyush
Q: XTRA This company seems to totally fly under the market’s radar. It develops and produces AI tech to provide physical security access at large venues and events. Financials are out soon and optimism is high. Recent multiple new contracts with major sports franchises, arenas and stadiums. Some major player customers (Tesla etc). The technology ought to be deployed at every school entrance across the US. Its major competitor is facing multiple lawsuits over its inferior product and is now embroiled in the New York Mayor/New York Subway contracts scandal. Seems to me the stock price should be on a steep upward projectile, yet it has remained stagnant for ages. What it is about Xtract that the marker doesn’t seem to like? Or is there something more nefarious at play to keep the stock price stifled? Thanks for all your advice and mentoring.